Bridge Port Financial Solutions, LLC Gilead Sciences, Inc. Transaction History
Bridge Port Financial Solutions, LLC
- $372 Billion
- Q3 2025
A detailed history of Bridge Port Financial Solutions, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bridge Port Financial Solutions, LLC holds 3,444 shares of GILD stock, worth $427,365. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,444
Previous 7,054
51.18%
Holding current value
$427,365
Previous $782 Million
51.12%
% of portfolio
0.1%
Previous 0.26%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...